
Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Research To Practice | Oncology Videos
00:00
AKT Inhibition (capivasertib) in Prostate Cancer
Matthew R Smith introduces capivasertib, the CAPItello-281 design, biomarker selection and awaiting detailed ESMO data.
Play episode from 09:10
Transcript


